company background image
GMED * logo

Globus Medical BMV:GMED * Stock Report

Last Price

Mex$1.89k

Market Cap

Mex$245.0b

7D

10.7%

1Y

n/a

Updated

07 Feb, 2025

Data

Company Financials +

Globus Medical, Inc.

BMV:GMED * Stock Report

Market Cap: Mex$245.0b

GMED * Stock Overview

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. More details

GMED * fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Globus Medical, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Globus Medical
Historical stock prices
Current Share PriceUS$1,888.19
52 Week HighUS$1,888.19
52 Week LowUS$990.00
Beta1.19
1 Month Change10.74%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change89.70%
Change since IPO102.40%

Recent News & Updates

Recent updates

Shareholder Returns

GMED *MX Medical EquipmentMX Market
7D10.7%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how GMED * performed against the MX Medical Equipment industry.

Return vs Market: Insufficient data to determine how GMED * performed against the MX Market.

Price Volatility

Is GMED *'s price volatile compared to industry and market?
GMED * volatility
GMED * Average Weekly Movementn/a
Medical Equipment Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: GMED *'s share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine GMED *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20035,000Dan Scavillawww.globusmedical.com

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

Globus Medical, Inc. Fundamentals Summary

How do Globus Medical's earnings and revenue compare to its market cap?
GMED * fundamental statistics
Market capMex$245.02b
Earnings (TTM)Mex$1.87b
Revenue (TTM)Mex$50.71b

130.9x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GMED * income statement (TTM)
RevenueUS$2.48b
Cost of RevenueUS$816.66m
Gross ProfitUS$1.66b
Other ExpensesUS$1.57b
EarningsUS$91.51m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 20, 2025

Earnings per share (EPS)0.67
Gross Margin67.05%
Net Profit Margin3.69%
Debt/Equity Ratio10.7%

How did GMED * perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:05
End of Day Share Price 2025/02/05 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Globus Medical, Inc. is covered by 27 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Matt MiksicBarclays
Craig BijouBofA Global Research